Literature DB >> 24797264

Identification of small ubiquitin-like modifier substrates with diverse functions using the Xenopus egg extract system.

Li Ma1, Aaron Aslanian2, Huaiyu Sun1, Mingji Jin1, Yu Shi1, John R Yates3, Tony Hunter4.   

Abstract

Post-translational modification by SUMO is a highly conserved pathway in eukaryotes that plays very important regulatory roles in many cellular processes. Deregulation of the SUMO pathway contributes to the development and progression of many diseases including cancer. Therefore, identifying additional SUMO substrates and studying how their cellular and biological functions are regulated by sumoylation should provide new insights. Our studies showed that sumoylation activity was significant in Xenopus egg extracts, and that a high level of sumoylation was associated with sperm chromatin when SUMO was incubated with Xenopus egg extracts. By isolating SUMO-conjugated substrates using His-tagged SUMO1 or SUMO2 proteins under denaturing conditions, we identified 346 proteins by mass spectrometry analysis that were not present in control pull-downs. Among them, 167 proteins were identified from interphase egg extracts, 86 proteins from mitotic phase egg extracts, and 93 proteins from both. Thirty-three proteins were pulled down by SUMO1, 85 proteins by SUMO2, and 228 proteins by both. We validated the sumoylation of five candidates, CKB, ATXN10, BTF3, HABP4, and BZW1, by co-transfecting them along with SUMO in HEK293T cells. Gene ontology analysis showed that SUMO substrates identified in this study were involved in diverse biological processes. Additionally, SUMO substrates identified from different cell cycle stages or pulled down by different SUMO homologs were enriched for distinct cellular components and functional categories. Our results comprehensively profile the sumoylation occurring in the Xenopus egg extract system.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24797264      PMCID: PMC4083107          DOI: 10.1074/mcp.M113.035626

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  59 in total

1.  SnapShot: The SUMO system.

Authors:  Sandrine Creton; Stefan Jentsch
Journal:  Cell       Date:  2010-11-24       Impact factor: 41.582

2.  Investigating mitotic spindle assembly and function in vitro using Xenopus laevis egg extracts.

Authors:  Eva Hannak; Rebecca Heald
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 3.  Concepts in sumoylation: a decade on.

Authors:  Ruth Geiss-Friedlander; Frauke Melchior
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

4.  bioDBnet: the biological database network.

Authors:  Uma Mudunuri; Anney Che; Ming Yi; Robert M Stephens
Journal:  Bioinformatics       Date:  2009-01-07       Impact factor: 6.937

5.  Uncovering SUMOylation dynamics during cell-cycle progression reveals FoxM1 as a key mitotic SUMO target protein.

Authors:  Joost Schimmel; Karolin Eifler; Jón Otti Sigurðsson; Sabine A G Cuijpers; Ivo A Hendriks; Matty Verlaan-de Vries; Christian D Kelstrup; Chiara Francavilla; René H Medema; Jesper V Olsen; Alfred C O Vertegaal
Journal:  Mol Cell       Date:  2014-02-27       Impact factor: 17.970

Review 6.  The creatine-creatine phosphate energy shuttle.

Authors:  S P Bessman; C L Carpenter
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

7.  Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2.

Authors:  H Saitoh; D B Sparrow; T Shiomi; R T Pu; T Nishimoto; T J Mohun; M Dasso
Journal:  Curr Biol       Date:  1998-01-15       Impact factor: 10.834

8.  Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling.

Authors:  Guoqiang Xu; Jeremy S Paige; Samie R Jaffrey
Journal:  Nat Biotechnol       Date:  2010-07-18       Impact factor: 54.908

9.  Ubiquitin/SUMO modification of PCNA promotes replication fork progression in Xenopus laevis egg extracts.

Authors:  Craig A Leach; W Matthew Michael
Journal:  J Cell Biol       Date:  2005-12-12       Impact factor: 10.539

10.  SUMO2/3 modification of cyclin E contributes to the control of replication origin firing.

Authors:  Catherine Bonne-Andrea; Malik Kahli; Francisca Mechali; Jean-Marc Lemaitre; Guillaume Bossis; Olivier Coux
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  6 in total

1.  Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.

Authors:  Ângela Saito; Edmarcia E Souza; Fernanda C Costa; Gabriela V Meirelles; Kaliandra A Gonçalves; Marcos T Santos; Gustavo C Bressan; Mark E McComb; Catherine E Costello; Stephen A Whelan; Jörg Kobarg
Journal:  J Proteome Res       Date:  2017-07-31       Impact factor: 4.466

Review 2.  SUMO-mediated regulation of DNA damage repair and responses.

Authors:  Prabha Sarangi; Xiaolan Zhao
Journal:  Trends Biochem Sci       Date:  2015-03-13       Impact factor: 13.807

3.  System-wide Analysis of SUMOylation Dynamics in Response to Replication Stress Reveals Novel Small Ubiquitin-like Modified Target Proteins and Acceptor Lysines Relevant for Genome Stability.

Authors:  Zhenyu Xiao; Jer-Gung Chang; Ivo A Hendriks; Jón Otti Sigurðsson; Jesper V Olsen; Alfred C O Vertegaal
Journal:  Mol Cell Proteomics       Date:  2015-03-09       Impact factor: 5.911

4.  SUMOylation of EHD3 Modulates Tubulation of the Endocytic Recycling Compartment.

Authors:  Or Cabasso; Olga Pekar; Mia Horowitz
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

5.  Comprehensive list of SUMO targets in Caenorhabditis elegans and its implication for evolutionary conservation of SUMO signaling.

Authors:  Krzysztof Drabikowski; Jacqueline Ferralli; Michal Kistowski; Jacek Oledzki; Michal Dadlez; Ruth Chiquet-Ehrismann
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

Review 6.  Developing Practical Therapeutic Strategies that Target Protein SUMOylation.

Authors:  Olivia F Cox; Paul W Huber
Journal:  Curr Drug Targets       Date:  2019       Impact factor: 3.465

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.